首页 | 本学科首页   官方微博 | 高级检索  
     

康复新药理作用的研究进展
引用本文:汤雁利,李罡,李启艳. 康复新药理作用的研究进展[J]. 西北药学杂志, 2014, 0(1): 103-106
作者姓名:汤雁利  李罡  李启艳
作者单位:[1]昆明医科大学,昆明650031 [2]云南省第一人民医院,昆明650032 [3]昆明理工大学附属昆华医院,昆明650032 [4]昆明医科大学附属口腔医院,昆明650031
基金项目:国家自然科学基金(编号:81160134);云南省中青年学术技术带头人后备人才培养项目(编号:2012HB027);云南省卫生厅卫生系统学科带头人培养项目(编号:15-201232)
摘    要:目的为康复新的进一步研究提供参考,为其临床合理应用和开发提供科学依据。方法检索中国知网、中国医院数字图书馆、万方医学网以及PubMed1994至2012年收载的公开发表的期刊杂志中有关康复新液和美洲大蠊的基础性研究文献并进行文献综述。结果对康复新药理作用进行综合整理、归纳、分析。结论康复新是用有机溶剂提取昆虫药材蟑螂体内的活性物质,分离而制成的生物制剂,具有药用价值广、不良反应少的特点。其药理作用包括促进创面愈合、抗炎、镇痛、抑制肿瘤细胞、增强免疫功能等。

关 键 词:康复新  美洲大蠊  药理作用

Research advances in pharmacological action of Kangfuxin
TANG Yanli,LI Gang,LI Qiyan. Research advances in pharmacological action of Kangfuxin[J]. Northwest Pharmaceutical Journal, 2014, 0(1): 103-106
Authors:TANG Yanli  LI Gang  LI Qiyan
Affiliation:1. Kunming Medical University, Kunming, 650031, China; 2. The First People's Hospital of Yunnan Province, Kunming, 650032, China; 3. The Affiliated Kunhua Hospital of Kunming University of Science and Technology, Kunming, 650032, China; 4. The Affiliated Stomatology Hospital of Kunming Medical University, Kunming, 650031, China)
Abstract:Obj ective To provide references for Kangfuxin′s further study and to provide evidences for its clinical usage and further developing.Methods The original articles,which were retrieved from Chinese Hownet,Hospital Digital Library in China,Wan-fang Medical Network,as well as PubMed,were reviewed.Results The pharmacological actions of Kangfuxin were sorted,gener-alized and analyzed.Conclusion Kangfuxin,a drug derived from Periplaneta americana,has high medical value and low side effects.Its pharmacological actions include promoting wound healing,anti-inflammation,pain relief,tumor cells inhibition,im-mune function enhancement,and so on.
Keywords:Kangfuxin  Periplaneta americana  pharmacological action
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号